NUVB FY 2023 Earnings — Nuvation Bio Inc. Revenue & Financial Results | Market Cap Arena

NUVBNuvation Bio Inc.

$2B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$100M

Net Income

-$76M

EPS (Diluted)

$-0.35

Cash Flow

Operating Cash Flow

-$68M

Free Cash Flow

-$68M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$621M

Total Liabilities

$16M

Stockholders' Equity

$605M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$100M	-$120M	+16.6%
Net Income	-$76M	-$104M	+27.3%